Status:
COMPLETED
Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)
Lead Sponsor:
Drexel University College of Medicine
Collaborating Sponsors:
MDA/ALS Center of Hope
Conditions:
Amyotrophic Lateral Sclerosis
Cerebrospinal Fluid
Eligibility:
All Genders
20-85 years
Brief Summary
Amyotrophic lateral sclerosis is a uniformly progressive and fatal neurodegenerative disorder for which there is no known cure. In a novel attempt to widen the search for potential therapeutic agents,...
Eligibility Criteria
Inclusion
- Diagnosis of definite or probable ALS by the El Escorial Criteria
- Participants must be medically able to undergo the study procedures
- Subjects must have a registered nurse who can administer the drug daily and also inspect the IV site
- Not Pregnant
- Willing to pay for the cost of drug, administration, and safety testing
- Able to give informed consent
Exclusion
- Patients who are not diagnosed with ALS by a physician
- Patients unable to give informed consent
- Patients who have a history of sensitivity to cephalosporin or penicillin antibiotics (such as Ancef, Keflex, Ceclor, Ceftin, Lorabid, Suprax, or Fortaz).
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00718393
Start Date
June 1 2007
End Date
October 1 2015
Last Update
March 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.